查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402926

牲畜疫苗市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Livestock Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 165 Pages | 商品交期: 2-10個工作天內

價格

牲畜疫苗市場 - 報告範圍

TMR 關於全球牲畜疫苗市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球牲畜疫苗市場的收入2017-2031年期間，考慮2023年為基準年，2031年為預測年。報告也提供了2023年至2031年全球牲畜疫苗市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解牲畜疫苗市場。

市場概況
2023年市場價值 54 億美元
2031 年市場價值 94 億美元
CAGR 6.4%

該報告深入探討了全球牲畜疫苗市場的競爭格局。全球牲畜疫苗市場的主要參與者已經確定，並對每個參與者的各種屬性進行了分析。公司概況、財務狀況、近期發展和 SWOT 是本報告中介紹的全球牲畜疫苗市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 疾病流行病學
  • 管道分析
  • 重要行業活動
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依疫苗類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依疫苗類型，2023-2031
    • 牛疫苗
    • 家禽疫苗
    • 豬疫苗
    • 其他
  • 市場吸引力分析：按疫苗類型

第 7 章：全球市場分析與預測：依技術分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2023-2031
    • 減毒活疫苗
    • 去活化疫苗
    • 重組疫苗
    • 其他
  • 市場吸引力分析：依技術分類

第 8 章：全球市場分析與預測：按管理途徑

  • 簡介與定義
  • 主要發現/進展
  • 市值預測：依給藥途徑，2023-2031
    • 口服
    • 注射用
    • 其他
  • 市場吸引力分析：按給藥途徑

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2023-2031
    • 獸醫院
    • 獸醫診所
    • 其他
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2023-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Dechra Pharmaceuticals PLC
    • Ceva Sante Animale
    • Elanco
    • Merck & Co., Inc.
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH.
    • Virbac
    • Biogenesis Bago
    • Ourofino Saude Animal
    • Other prominent Players
Product Code: TMRGL85857

Livestock Vaccines Market - Scope of Report

TMR's report on the global livestock vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global livestock vaccines market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global livestock vaccines market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the livestock vaccines market.

Market Snapshot
Market Value in 2023US$ 5.4 Bn
Market Value in 2031US$ 9.4 Bn
CAGR6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global livestock vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global livestock vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global livestock vaccines market.

The report delves into the competitive landscape of the global livestock vaccines market. Key players operating in the global livestock vaccines market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global livestock vaccines market profiled in this report.

Key Questions Answered in Global livestock vaccines Market Report:

  • What is the sales/revenue generated by livestock vaccines across all regions during the forecast period?
  • What are the opportunities in the global livestock vaccines market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Livestock Vaccines Market - Research Objectives and Research Approach

The comprehensive report on the global livestock vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global livestock vaccines market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global livestock vaccines market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Livestock Vaccines Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. Key Industry Events
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Vaccine Type, 2023-2031
    • 6.3.1. Bovine Vaccine
    • 6.3.2. Poultry Vaccine
    • 6.3.3. Porcine Vaccine
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Vaccine Type

7. Global Livestock Vaccines Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2023-2031
    • 7.3.1. Live Attenuated Vaccine
    • 7.3.2. Inactivated Vaccine
    • 7.3.3. Recombinant Vaccine
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Livestock Vaccines Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2023-2031
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Livestock Vaccines Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2023-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Livestock Vaccines Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 11.2.1. Bovine Vaccine
    • 11.2.2. Poultry Vaccine
    • 11.2.3. Poultry Vaccine
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Technology, 2023-2031
    • 11.3.1. Live Attenuated Vaccine
    • 11.3.2. Inactivated Vaccine
    • 11.3.3. Recombinant Vaccine
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2023-2031
    • 11.5.1. Veterinary Hospitals
    • 11.5.2. Veterinary Clinics
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2023-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Vaccine Type
    • 11.7.2. By Technology
    • 11.7.3. By Route of Administration
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Livestock Vaccines Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 12.2.1. Bovine Vaccine
    • 12.2.2. Poultry Vaccine
    • 12.2.3. Porcine Vaccine
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Technology, 2023-2031
    • 12.3.1. Live Attenuated Vaccine
    • 12.3.2. Inactivated Vaccine
    • 12.3.3. Recombinant Vaccine
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2023-2031
    • 12.5.1. Veterinary Hospitals
    • 12.5.2. Veterinary Clinics
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Vaccine Type
    • 12.7.2. By Technology
    • 12.7.3. By Route of Administration
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Livestock Vaccines Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 13.2.1. Bovine Vaccine
    • 13.2.2. Poultry Vaccine
    • 13.2.3. Porcine Vaccine
    • 13.2.4. others
  • 13.3. Market Value Forecast, by Technology, 2023-2031
    • 13.3.1. Live Attenuated Vaccine
    • 13.3.2. Inactivated Vaccine
    • 13.3.3. Recombinant Vaccine
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2023-2031
    • 13.5.1. Veterinary Hospitals
    • 13.5.2. Veterinary Clinics
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Vaccine Type
    • 13.7.2. By Technology
    • 13.7.3. By Route of Administration
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Livestock Vaccines Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 14.2.1. Bovine Vaccine
    • 14.2.2. Poultry Vaccine
    • 14.2.3. Porcine Vaccine
    • 14.2.4. Others Vaccine
  • 14.3. Market Value Forecast, by Technology, 2023-2031
    • 14.3.1. Live Attenuated Vaccine
    • 14.3.2. Inactivated Vaccine
    • 14.3.3. Recombinant Vaccine
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2023-2031
    • 14.5.1. Veterinary Hospitals
    • 14.5.2. Veterinary Clinics
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Vaccine Type
    • 14.7.2. By Technology
    • 14.7.3. By Route of Administration
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Vaccine Type, 2023-2031
    • 15.2.1. Bovine Vaccine
    • 15.2.2. Poultry Vaccine
    • 15.2.3. Porcine Vaccine
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Technology, 2023-2031
    • 15.3.1. Live Attenuated Vaccine
    • 15.3.2. Inactivated Vaccine
    • 15.3.3. Recombinant Vaccine
    • 15.3.4. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2023-2031
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2023-2031
    • 15.5.1. Veterinary Hospitals
    • 15.5.2. Veterinary Clinics
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Vaccine Type
    • 15.7.2. By Technology
    • 15.7.3. By Route of Administration
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Dechra Pharmaceuticals PLC
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Ceva Sante Animale
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Elanco
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck & Co., Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Zoetis Services LLC
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Boehringer Ingelheim International GmbH.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Virbac
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Biogenesis Bago
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Ourofino Saude Animal
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. VETAL Animal Health Products, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Other prominent Players
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 02: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 03: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 04: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 05: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 06: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 07: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 08: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 09: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 10: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 11: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 12: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 13: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 14: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 15: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 18: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 19: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 20: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 21: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 23: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 24: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 25: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 26: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 27: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023-2031
  • Table 28: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 29: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 30: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023-2031

List of Figures

  • Figure 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Livestock Vaccines Market Value Share, by Vaccine Type, 2022
  • Figure 03: Livestock Vaccines Market Value Share, by Technology, 2022
  • Figure 04: Livestock Vaccines Market Value Share, by Route of Administration, 2022
  • Figure 05: Global Livestock Vaccines Market Value Share, by End-user, 2022
  • Figure 06: Global Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 07: Global Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 08: Global Livestock Vaccines Market Revenue (US$ Mn), by Bovine Vaccine , 2023-2031
  • Figure 09: Global Livestock Vaccines Market Revenue (US$ Mn), by Poultry Vaccine, 2023-2031
  • Figure 10: Global Livestock Vaccines Market Revenue (US$ Mn), by Porcine Vaccine, 2023-2031
  • Figure 11: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 12: Global Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 13: Global Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 14: Global Livestock Vaccines Market Value (US$ Mn), by Live Attenuated Vaccine, 2023-2031
  • Figure 15: Global Livestock Vaccines Market Value (US$ Mn), by Inactivated Vaccine, 2023-2031
  • Figure 16: Global Livestock Vaccines Market Value (US$ Mn), by Recombinant Vaccine, 2023-2031
  • Figure 17: Global Livestock Vaccines Market Value (US$ Mn), by Others, 2023-2031
  • Figure 18: Global Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 19: Global Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 20: Global Livestock Vaccines Market Revenue (US$ Mn), by Oral , 2023-2031
  • Figure 21: Global Livestock Vaccines Market Revenue (US$ Mn), by Parenteral, 2023-2031
  • Figure 22: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 23: Global Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Hospitals, 2023-2031
  • Figure 26: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Clinics, 2023-2031
  • Figure 27: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023-2031
  • Figure 28: Global Livestock Vaccines Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global Livestock Vaccines Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 31: North America Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 34: North America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 35: North America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 36: North America Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 37: North America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 38: North America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 39: North America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 42: Europe Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 43: Europe Livestock Vaccines Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 44: Europe Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 45: Europe Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 46: Europe Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 47: Europe Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 48: Europe Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Europe Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 50: Europe Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Europe Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 53: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 56: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 57: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 58: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 59: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 60: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 61: Asia Pacific Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 64: Latin America Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 65: Latin America Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 66: Latin America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 67: Latin America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 68: Latin America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 69: Latin America Livestock Vaccines Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 70: Latin America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 71: Latin America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023-2031
  • Figure 72: Latin America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 74: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 75: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 76: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 77: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
  • Figure 78: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023-2031
  • Figure 79: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 80: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Technology 2023-2031
  • Figure 81: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 82: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 83: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 84: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 85: Global Livestock Vaccines Market Share Analysis By Company (2022)